Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

NCT07558850 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Dermatomyositis
Systemic Lupus Erythematosus
Systemic Sclerosis

Interventions

BIOLOGICAL: anti-CD19/BCMA-UCAR-T cells

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]